Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor

Gupta, N; Hanley, MJ; Griffin, RJ; Zhang, PK; Venkatakrishnan, K; Sinha, V

Gupta, N (通讯作者)，Takeda Dev Ctr Amer Inc, Lexington, MA 02421 USA.;Gupta, N (通讯作者)，Takeda Dev Ctr Amer Inc, 40 Landsdowne St, Cambridge, MA 02139 USA.

CLINICAL PHARMACOKINETICS, 2023; ():

Abstract

Brigatinib, a next-generation anaplastic lymphoma kinase (ALK) inhibitor designed to overcome mechanisms of resistance associated with crizotinib, is ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索